Does aimovig cause hair loss?

Does Aimovig cause hair loss?

Doctors sometimes report hair loss in patients taking Aimovig, but large clinical trials did not list it as a common side effect. Hair loss appears in post-marketing reports and in some smaller observational studies at rates under 2 percent.

Why are patients reporting hair loss with Aimovig?

People notice shedding weeks to months after starting the drug. Most cases are described as mild and reversible after stopping treatment. The mechanism is unclear, though CGRP blockade could theoretically affect hair follicle cycling.

How common is hair loss compared with other CGRP inhibitors?

Similar low-level reports exist for Emgality, Ajovy, and Vyepti. No head-to-head studies show one drug in the class is more likely to cause hair loss than another.

What should patients do if they notice hair loss on Aimovig?

Contact the prescriber. They may check for other causes such as thyroid issues, iron deficiency, or stress before deciding whether to switch therapies. Most people continue treatment if the migraine benefit outweighs the cosmetic concern.

Does the Aimovig label mention hair loss?

The official prescribing information does not list alopecia. The FDA’s adverse-event database contains hundreds of reports, but these cannot prove causation.

When does hair usually grow back after stopping Aimovig?

Regrowth often starts within three to six months, though timelines vary. Some patients see improvement while still on therapy.

Are there alternatives if hair loss becomes a problem?

Switching to a different CGRP antibody or to an oral gepant such as Ubrelvy or Nurtec ODT may reduce the issue. Non-CGRP options like topiramate or Botox remain available for some patients.

DrugPatentWatch.com tracks Aimovig’s remaining patent life and biosimilar entry dates that could affect future pricing and access.